@NP	Differing Schwann Cells and Olfactory Ensheathing Cells Behaviors	1
@NP	Differing Schwann Cells	1
@NP	Olfactory Ensheathing Cells Behaviors	29
@NP	Astrocyte	90
@NP	Similar Improvements	109
@NP	Contused Rat	133
@NP	Spinal Cord 's Motor Function	146
@NP	Spinal Cord 's	146
@NP	Bing Cang Li & Chuan Xu & Jie Yuan Zhang & Yue Li & Zhao Xia Duan Abstract	176
@NP	recent years	255
@NP	cell behaviors	269
@NP	Schwann cells -LRB- SCs -RRB- and olfactory ensheathing cells -LRB- OECs -RRB-	287
@NP	Schwann cells	287
@NP	SCs	302
@NP	olfactory ensheathing cells	311
@NP	OECs	340
@NP	astrocytes	368
@NP	spinal cord injury model of dorsal crush and transection	423
@NP	spinal cord injury model	423
@NP	dorsal crush and transection	451
@NP	normal white matter	487
@NP	this study	511
@NP	a candidate	549
@NP	cell-mediated repair of the spinal cord injury	565
@NP	cell-mediated repair	565
@NP	the spinal cord injury	589
@NP	SCs or OECs	613
@NP	contused spinal cord in adult rats	648
@NP	contused spinal cord	648
@NP	adult rats	672
@NP	The interaction with host astrocytes	684
@NP	The interaction	684
@NP	host astrocytes	705
@NP	3 and 6 weeks after transplantation	737
@NP	3 and 6 weeks	737
@NP	transplantation	757
@NP	light and electron microscope	779
@NP	The motor function of the rat	810
@NP	The motor function	810
@NP	the rat	832
@NP	the BBB locomotor rating scale	859
@NP	cortical somatosensory	894
@NP	potentials -LRB- CSEP -RRB- recording	924
@NP	potentials -LRB- CSEP -RRB-	924
@NP	potentials	924
@NP	CSEP	936
@NP	SCs cord	960
@NP	the astrocytes	970
@NP	proliferation and hypertrophy	995
@NP	The myelinated axons	1026
@NP	the groups	1067
@NP	the glial membrane	1081
@NP	OECs cord	1108
@NP	astrocytes	1119
@NP	the proliferation and hypertrophy	1146
@NP	The myelinated axons	1181
@NP	groups	1224
@NP	the scar tissue	1234
@NP	SCs graft , compared with OECs graft ,	1251
@NP	SCs graft	1251
@NP	OECs graft	1276
@NP	more	1296
@NP	glial fibrillary acidic protein -LRB- GFAP -RRB- immunoreactivity	1310
@NP	GFAP	1343
@NP	a distinct astroglial border between the normal and injured tissues	1371
@NP	a distinct astroglial border	1371
@NP	the normal and injured tissues	1408
@NP	The distribution of SCs	1440
@NP	The distribution	1440
@NP	SCs	1460
@NP	that of OECs	1509
@NP	that	1509
@NP	OECs	1517
@NP	SCs	1523
@NP	weaker NF immunoreactivity and functional recovery	1535
@NP	weaker NF immunoreactivity	1535
@NP	functional recovery	1566
@NP	OECs	1598
@NP	no significant differences between the two groups	1608
@NP	no significant differences	1608
@NP	the two groups	1643
@NP	the statistical analysis	1674
@NP	we	1703
@NP	this	1712
@NP	first time to compare behaviors of SCs and OECs in the contusion model	1720
@NP	behaviors of SCs and OECs	1742
@NP	behaviors	1742
@NP	SCs and OECs	1755
@NP	the contusion model	1771
@NP	the data	1796
@NP	cell behaviors of SCs and OECs	1837
@NP	cell behaviors	1837
@NP	SCs and OECs	1855
@NP	astrocyte	1902
@NP	both cell types	1913
@NP	the motor function of the contused rats	1941
@NP	the motor function	1941
@NP	the contused rats	1963
@NP	Introduction	1983
@NP	spinal cord injury -LRB- SCI -RRB-	2002
@NP	spinal cord injury	2002
@NP	SCI	2022
@NP	a series of cellular and molecular events	2028
@NP	a series	2028
@NP	cellular and molecular events	2040
@NP	glial scar	2081
@NP	Astrocytes	2093
@NP	response	2121
@NP	injury	2133
@NP	the synthesis	2155
@NP	glial fibrillary acidic protein -LRB- GFAP -RRB-	2172
@NP	glial fibrillary acidic protein	2172
@NP	GFAP	2205
@NP	Fawcet and Asher 1999	2212
@NP	Fawcet	2212
@NP	Asher 1999	2223
@NP	The most dramatic responses of astrocytes	2236
@NP	The most dramatic responses	2236
@NP	astrocytes	2267
@NP	the formation	2287
@NP	the glial scar	2304
@NP	the extensive hypertrophy of the cell body and cytoplasmic processes	2341
@NP	the extensive hypertrophy	2341
@NP	the cell body and cytoplasmic processes	2370
@NP	the cell body	2370
@NP	cytoplasmic processes	2388
@NP	this scar	2420
@NP	necrotic tissue	2452
@NP	non-neural cells	2480
@NP	the tissue cavity resulting from injury -LRB- Eddleston and Mucke 1993 -RRB-	2505
@NP	the tissue cavity	2505
@NP	injury -LRB- Eddleston and Mucke 1993 -RRB-	2538
@NP	injury	2538
@NP	Eddleston and Mucke 1993	2546
@NP	Eddleston	2546
@NP	Mucke 1993	2560
@NP	it	2573
@NP	axonal regeneration -LRB- Silver and Miller 2004 ; Pekny and Nilsson 2005 -RRB-	2590
@NP	axonal regeneration	2590
@NP	Silver and Miller 2004 ; Pekny and Nilsson 2005	2611
@NP	Silver and Miller 2004 ; Pekny and Nilsson	2611
@NP	Silver and Miller 2004	2611
@NP	Silver	2611
@NP	Miller 2004	2622
@NP	Pekny and Nilsson	2635
@NP	Pekny	2635
@NP	Nilsson	2645
@NP	2005	2653
@NP	SCs and OECs	3133
@NP	common growth factor responses -LRB- Pollock et al. 1999 -RRB-	3152
@NP	common growth factor responses	3152
@NP	Pollock	3184
@NP	et al. 1999	3192
@NP	et al.	3192
@NP	1999	3199
@NP	antigenic and morphological characteristics	3206
@NP	Franceschini and Barnett 1996	3251
@NP	Franceschini	3251
@NP	Barnett 1996	3268
@NP	transcriptional regulation	3287
@NP	Smith	3315
@NP	et al. 2001	3321
@NP	et al.	3321
@NP	2001	3328
@NP	they	3335
@NP	reactive astrocyte response	3359
@NP	Lakatos et al. 2000 ; Fairless et al. 2005	3397
@NP	Lakatos	3397
@NP	et al. 2000 ; Fairless et al. 2005	3405
@NP	et al. 2000	3405
@NP	et al.	3405
@NP	2000	3412
@NP	Fairless et al. 2005	3418
@NP	Fairless	3418
@NP	et al.	3427
@NP	2005	3434
@NP	vivo -LRB- Lakatos et al. 2003 ; Santos-Silva et al. 2007 -RRB-	3447
@NP	vivo	3447
@NP	Lakatos	3453
@NP	et al. 2003 ; Santos-Silva et al. 2007	3461
@NP	et al. 2003 ; Santos-Silva et al.	3461
@NP	et al. 2003	3461
@NP	et al.	3461
@NP	2003	3468
@NP	Santos-Silva et al.	3474
@NP	Santos-Silva	3474
@NP	et al.	3487
@NP	2007	3494
@NP	assays	3516
@NP	both SCs and OECs	3533
@NP	SCs	3538
@NP	OECs	3546
@NP	astrocyte monolayers	3566
@NP	OECs	3597
@NP	an area containing astrocytes	3620
@NP	an area	3620
@NP	astrocytes	3639
@NP	Astrocytes	3651
@NP	hypertrophy when	3670
@NP	hypertrophy	3670
@NP	contact with SCs	3690
@NP	contact	3690
@NP	SCs	3703
@NP	OECs -LRB- Lakatos et al. 2000 -RRB-	3720
@NP	OECs	3720
@NP	Lakatos	3726
@NP	et al. 2000	3734
@NP	et al.	3734
@NP	2000	3741
@NP	It	3748
@NP	astrocytes	3788
@NP	OECs but not SCs after injection	3811
@NP	OECs but not SCs	3811
@NP	injection	3834
@NP	normal spinal cord -LRB- Santos-Silva et al. 2007 -RRB-	3849
@NP	normal spinal cord	3849
@NP	Santos-Silva	3869
@NP	et al. 2007	3882
@NP	et al.	3882
@NP	2007	3889
@NP	this study	3899
@NP	SCs and OECs	3911
@NP	olfactory bulb and sciatic nerve of transgenic rat	3946
@NP	olfactory bulb and sciatic nerve	3946
@NP	transgenic rat	3982
@NP	green fluorescence protein	4002
@NP	GFP	4030
@NP	the contused spinal cord	4053
@NP	the	4053
@NP	spinal cord	4066
@NP	Their behaviors when interacting with astrocyte and glial scar	4079
@NP	Their behaviors	4079
@NP	astrocyte and glial scar	4117
@NP	astrocyte	4117
@NP	glial scar	4131
@NP	semi-quantitative analysis and ultrastructural description	4162
@NP	semi-quantitative analysis	4162
@NP	ultrastructural description	4193
@NP	the motor function of the contused rat	4236
@NP	the motor function	4236
@NP	the contused rat	4258
@NP	the BBB locomotor rating scale	4288
@NP	cortical somatosensory	4323
@NP	potentials -LRB- CSEP -RRB- recording	4353
@NP	potentials -LRB- CSEP -RRB-	4353
@NP	potentials	4353
@NP	CSEP	4365
@NP	Our results	4382
@NP	the previous reports	4402
@NP	OECs	4428
@NP	glial scar	4451
@NP	more	4471
@NP	SCs	4493
@NP	GFAP immunocytochemistry	4505
@NP	it	4540
@NP	SCs	4560
@NP	collagen membrane	4582
@NP	hypertrophic astrocytes	4619
@NP	the OECs	4650
@NP	SCs	4677
@NP	weaker neurofilament -LRB- NF -RRB- immunoreactivity	4689
@NP	weaker neurofilament	4689
@NP	NF	4711
@NP	immunoreactivity	4715
@NP	functional recovery compared to OECs	4736
@NP	functional recovery	4736
@NP	OECs	4768
@NP	both cells	4774
@NP	the motor function of contused rat spinal cord	4799
@NP	the motor function	4799
@NP	contused rat spinal cord	4821
@NP	These results	4847
@NP	candidate transplant cells in human SCI therapy	4894
@NP	candidate transplant cells	4894
@NP	human SCI therapy	4924
@NP	the future	4945
@NP	Materials	4958
@NP	Methods Preparation	4972
@NP	SCs and OECs from GFP Rats Sciatic nerves and olfactory bulbs	4995
@NP	SCs and OECs	4995
@NP	GFP Rats Sciatic nerves and olfactory bulbs	5013
@NP	GFP Rats Sciatic nerves	5013
@NP	olfactory bulbs	5041
@NP	adult GFP rats	5075
@NP	SCs	5091
@NP	modified method described in Lankford et al.	5124
@NP	modified method	5124
@NP	Lankford	5153
@NP	et al.	5162
@NP	2002	5169
@NP	nerves	5184
@NP	scalpel blades	5223
@NP	incubation	5245
@NP	45 min	5260
@NP	Collagenase A	5270
@NP	Collagenase D -LRB- 1 mg/ml each , Roche , Indianapolis , IN -RRB-	5288
@NP	Collagenase D	5288
@NP	1 mg/ml each , Roche , Indianapolis	5303
@NP	1 mg/ml	5303
@NP	each	5311
@NP	Roche , Indianapolis	5317
@NP	15 min in 0.5 mg/ml trypsin -LRB- Worthington , Lakewood , NJ -RRB-	5355
@NP	15 min	5355
@NP	0.5 mg/ml trypsin -LRB- Worthington , Lakewood , NJ -RRB-	5365
@NP	0.5 mg/ml trypsin	5365
@NP	Worthington	5384
@NP	Lakewood	5397
@NP	NJ	5407
@NP	fire polished pipettes	5444
@NP	Non-dissociated tissue	5468
@NP	the cell suspension	5516
@NP	a 70-μm cell strainer -LRB- Falcon -RRB-	5541
@NP	a 70-μm cell strainer	5541
@NP	Falcon	5564
@NP	OECs	5573
@NP	detail in Sasaki et al. 2004	5608
@NP	detail	5608
@NP	Sasaki et al. 2004	5618
@NP	et al. 2004	5625
@NP	et al.	5625
@NP	2004	5632
@NP	the caudal two thirds of the olfactory bulbs	5647
@NP	the caudal two thirds	5647
@NP	the olfactory bulbs	5672
@NP	meninges and white matter	5714
@NP	meninges	5714
@NP	white matter	5727
@NP	scalpel blades	5753
@NP	25 min	5787
@NP	collagenase A -LRB- 0.75 mg/ml Roche -RRB-	5797
@NP	collagenase A	5797
@NP	0.75 mg/ml Roche	5812
@NP	collagenase D -LRB- 0.75 mg/ml , Roche -RRB-	5831
@NP	collagenase D	5831
@NP	0.75 mg/ml	5846
@NP	Roche	5858
@NP	papain -LRB- 12 U/ml , Worthington -RRB-	5870
@NP	papain	5870
@NP	12 U/ml	5878
@NP	Worthington	5887
@NP	calcium-free complete saline solution with trace cysteine	5903
@NP	calcium-free complete saline solution	5903
@NP	trace cysteine	5946
@NP	37 °C on a rotary shaker in a CO2 incubator	5964
@NP	37 °C	5964
@NP	a rotary shaker in a CO2 incubator	5973
@NP	a rotary shaker	5973
@NP	a CO2 incubator	5992
@NP	Tissue	6009
@NP	very gentle mechanical trituration	6042
@NP	a culture flask for 1 h in DMEMwith	6100
@NP	a culture flask	6100
@NP	1 h in DMEMwith	6120
@NP	1 h	6120
@NP	DMEMwith	6127
@NP	10 % FCS before removing and washing nonadherent cells	6136
@NP	10 % FCS	6136
@NP	nonadherent cells	6173
@NP	All cells	6192
@NP	three times	6214
@NP	DMEMonly	6229
@NP	30,000 cells per microliter	6262
@NP	30,000 cells	6262
@NP	microliter	6279
@NP	identification	6295
@NP	the isolated cells	6311
@NP	poly-L-lysine coated chamber slides	6356
@NP	DMEM	6408
@NP	10 % FCS and penicillin/streptomycin	6418
@NP	5 -- 7 days	6462
@NP	5	6462
@NP	7 days	6464
@NP	the cells	6472
@NP	ice-cold methanol	6498
@NP	rabbit anti-p75	6533
@NP	Chemicon Temecula	6550
@NP	USA	6569
@NP	mouse anti-S-100	6578
@NP	Chemicon Temecula	6596
@NP	USA	6615
@NP	primary antibodies	6620
@NP	Alexiflour 488 goat anti-mouse -LRB- 1:1,000 , Molecular Probes , USA -RRB-	6656
@NP	Alexiflour 488 goat anti-mouse	6656
@NP	Alexiflour	6656
@NP	488 goat	6667
@NP	1:1,000	6688
@NP	Molecular Probes	6697
@NP	USA	6715
@NP	594 goat	6724
@NP	1:1,000 , Molecular Probes , USA	6746
@NP	1:1,000	6746
@NP	Molecular Probes	6755
@NP	USA	6773
@NP	Hoechst 33358 -LRB- 1:1,000 , Molecular Probes , USA -RRB- nuclear stain	6824
@NP	Hoechst 33358 -LRB- 1:1,000 , Molecular Probes , USA -RRB-	6824
@NP	Hoechst 33358	6824
@NP	1:1,000	6839
@NP	Molecular Probes	6848
@NP	USA	6866
@NP	nuclear	6871
@NP	Antibody staining	6886
@NP	at least 95 % of donor cells	6929
@NP	at least 95 %	6929
@NP	donor cells	6946
@NP	P75 and S-100 positive	6968
@NP	P75 and S-100	6968
@NP	Contusion Injury Adult male Sprague	6992
@NP	Dawley	7028
@NP	SD	7036
@NP	rats -LRB- 200 -- 250 g -RRB-	7040
@NP	rats	7040
@NP	200 -- 250 g	7046
@NP	200	7046
@NP	250 g	7050
@NP	the Third Military Medical University -LRB- TMMU -RRB- guidelines	7082
@NP	TMMU	7121
@NP	surgical procedures and post-op care	7143
@NP	surgical procedures	7143
@NP	post-op care	7167
@NP	accordance	7198
@NP	protocols approved by TMMU Institutional Animal Care and Use Committee	7214
@NP	protocols	7214
@NP	TMMU Institutional Animal Care and Use Committee	7236
@NP	Rats	7286
@NP	a single intraperitoneal injection	7314
@NP	3 % sodium pentobarbiturate -LRB- 40 -- 50 mg/kg -RRB-	7352
@NP	3 % sodium pentobarbiturate	7352
@NP	40 -- 50 mg/kg	7381
@NP	40	7381
@NP	50 mg/kg	7384
@NP	a sterile laminectomy	7399
@NP	vertebral levels T10	7438
@NP	the dura	7478
@NP	The spinal cords	7488
@NP	an NYU-II impactor	7525
@NP	a dropping weight -LRB- 10.0 g -RRB- from 25mmabove	7549
@NP	a dropping weight -LRB- 10.0 g -RRB-	7549
@NP	a dropping weight	7549
@NP	10.0 g	7568
@NP	25mmabove	7581
@NP	the exposed cord -LRB- Basso et al. 1996 -RRB-	7591
@NP	the exposed cord	7591
@NP	Basso	7609
@NP	et al. 1996	7615
@NP	et al.	7615
@NP	1996	7622
@NP	injury	7635
@NP	the muscles and skin	7643
@NP	the muscles	7643
@NP	skin	7659
@NP	layers	7679
@NP	The procedure	7687
@NP	hind limb paralysis	7713
@NP	all animals	7736
@NP	wound and bladder infections	7760
@NP	Bicillin -LRB- 60,000 U/kg , i.m. -RRB-	7790
@NP	Bicillin	7790
@NP	60,000 U/kg , i.m.	7800
@NP	60,000 U/kg	7800
@NP	i.m.	7813
@NP	7 days	7839
@NP	bladder expression performed twice daily for 7 days after contusion	7851
@NP	bladder expression	7851
@NP	7 days	7896
@NP	contusion	7909
@NP	Transplantation of SCs and OECs Seven days after the initial surgery , the rats	7920
@NP	Transplantation	7920
@NP	SCs and OECs Seven days after the initial surgery , the rats	7939
@NP	SCs and OECs	7939
@NP	Seven days	7952
@NP	the initial surgery , the rats	7969
@NP	the initial surgery	7969
@NP	the rats	7990
@NP	the cords	8023
@NP	the same site	8052
@NP	One microliter cell suspension	8067
@NP	the midline	8117
@NP	the contused cord at a depth of 0.8 mm at the epicenter of the lesion	8132
@NP	the	8132
@NP	cord	8145
@NP	a depth of 0.8 mm	8153
@NP	a depth	8153
@NP	0.8 mm	8164
@NP	the epicenter of the lesion	8174
@NP	the epicenter	8174
@NP	the lesion	8191
@NP	1 mm rostral and caudal to the epicenter	8210
@NP	1 mm rostral	8210
@NP	caudal to the epicenter	8227
@NP	caudal	8227
@NP	the epicenter	8237
@NP	a total of 3 μl of cell suspension	8252
@NP	a total	8252
@NP	3 μl of cell suspension	8263
@NP	3 μl	8263
@NP	cell suspension	8271
@NP	The cell injections	8297
@NP	a drawn glass micropipette	8338
@NP	place for 5 min	8384
@NP	place	8384
@NP	5 min	8394
@NP	each injection	8406
@NP	The control animals	8422
@NP	identical volumes of DMEM	8459
@NP	identical volumes	8459
@NP	DMEM	8480
@NP	the same sites	8488
@NP	the injection	8510
@NP	the muscle and skin	8525
@NP	interrupted sutures	8562
@NP	The survival time of the animals	8583
@NP	The survival time	8583
@NP	the animals	8604
@NP	3 weeks -LRB- n015 -RRB- and 6 weeks -LRB- n015 -RRB-	8620
@NP	3 weeks -LRB- n015 -RRB-	8620
@NP	n015	8629
@NP	6 weeks -LRB- n015 -RRB-	8639
@NP	n015	8648
@NP	Histological Procedures and Semi-Quantification	8655
@NP	Histological Procedures	8655
@NP	Semi-Quantification	8683
@NP	3 and 6 weeks after transplantation	8706
@NP	3 and 6 weeks	8706
@NP	transplantation	8726
@NP	the host rats	8743
@NP	physiological saline	8791
@NP	4 % paraformaldehyde for frozen sectioning	8825
@NP	4 % paraformaldehyde	8825
@NP	frozen sectioning	8850
@NP	2 % paraformaldehyde and 2 % glutaraldehyde	8871
@NP	2 % paraformaldehyde	8871
@NP	2 % glutaraldehyde	8896
@NP	PBS -LRB- pH 7.4 -RRB- for plastic sectioning	8918
@NP	PBS -LRB- pH 7.4 -RRB-	8918
@NP	PBS	8918
@NP	pH 7.4	8923
@NP	plastic sectioning	8935
@NP	the spinal cords	8961
@NP	4 % paraformaldehyde for frozen sections	9009
@NP	4 % paraformaldehyde	9009
@NP	frozen sections	9032
@NP	3 % glutaraldehyde for plastic sections	9051
@NP	3 % glutaraldehyde	9051
@NP	plastic sections	9073
@NP	Frozen longitudinal serial sections of the spinal cords	9091
@NP	Frozen longitudinal serial sections	9091
@NP	the spinal cords	9130
@NP	a thickness of 15 μm on a LEICA Cryostat	9159
@NP	a thickness	9159
@NP	15 μm on a LEICA Cryostat	9174
@NP	15 μm	9174
@NP	a LEICA Cryostat	9183
@NP	a heating plate	9210
@NP	Aqua Poly / Mount -LRB- Polyscience , Inc. -RRB-	9243
@NP	Aqua Poly / Mount	9243
@NP	Aqua Poly	9243
@NP	Mount	9254
@NP	Polyscience	9261
@NP	Inc.	9274
@NP	The sections	9281
@NP	Olympus fluorescence microscope	9314
@NP	DP71 digital camera and software	9368
@NP	DP71 digital camera	9368
@NP	software	9392
@NP	All lesions	9402
@NP	both FITC and Rodamine excitation wavelengths	9431
@NP	FITC	9436
@NP	Rodamine excitation wavelengths	9445
@NP	transplanted SCs and OECs which fluoresce only in the green wavelength	9500
@NP	transplanted SCs and OECs	9500
@NP	the green wavelength	9550
@NP	macrophages autoflouresce	9577
@NP	all wavelengths	9606
@NP	The digital images	9623
@NP	20 ×	9660
@NP	Adobe Phostoshop 10.0	9682
@NP	measurements of cell distribution	9718
@NP	measurements	9718
@NP	cell distribution	9734
@NP	duplication	9760
@NP	Spot 345 software	9773
@NP	Spot	9773
@NP	345 software	9778
@NP	the distribution and migration of SCs and OECs	9811
@NP	the distribution and migration	9811
@NP	SCs and OECs	9845
@NP	the contused cord	9861
@NP	the	9861
@NP	cord	9874
@NP	Plastic coronal semi-thin sections -LRB- 1 um -RRB-	9880
@NP	Plastic coronal semi-thin sections	9880
@NP	1 um	9916
@NP	tissue blocks	9978
@NP	Sections	9993
@NP	methylene blue/Azure II	10020
@NP	the lesion and location under Olympus BX50 microscope	10061
@NP	the lesion and location	10061
@NP	Olympus BX50 microscope	10091
@NP	ultra-thin sections -LRB- 0.6 μm -RRB-	10121
@NP	ultra-thin sections	10121
@NP	0.6 μm	10142
@NP	the tissue blocks embedded plastically	10164
@NP	the tissue	10164
@NP	uranyl	10224
@NP	salts	10240
@NP	a TECNT 10 electron microscope -LRB- Netherlands -RRB-	10265
@NP	a TECNT 10 electron microscope	10265
@NP	Netherlands	10297
@NP	Immunohistochemistry	10311
@NP	GFAP and Neurofilament and Semi-Quantification Longitudinal cryo-sections	10335
@NP	PBS for 30 min	10424
@NP	PBS	10424
@NP	30 min	10432
@NP	solution	10467
@NP	PBS , 1 % BSA , 0.3 % Triton X-100 , 5 % normal goat serum	10477
@NP	PBS	10477
@NP	1 % BSA , 0.3 % Triton X-100 , 5 % normal goat serum	10482
@NP	1 % BSA	10482
@NP	0.3 % Triton X-100	10491
@NP	5 % normal goat serum	10511
@NP	1 h at room temperature	10538
@NP	1 h	10538
@NP	room temperature	10545
@NP	the sections	10569
@NP	the primary antibodies	10602
@NP	mouse anti-GFAP monoclonal antibody	10628
@NP	1:200 , Sigma , Saint Louis , USA	10665
@NP	1:200	10665
@NP	Sigma	10672
@NP	Saint Louis	10679
@NP	USA	10692
@NP	mouse anti-NF monoclonal antibody	10701
@NP	1:200 ; Chemicon Inc. , Temecula , CA , USA	10736
@NP	1:200	10736
@NP	Chemicon Inc. , Temecula , CA , USA	10743
@NP	1 h at room temperature and 24 h at 4 °C	10781
@NP	1 h at room temperature	10781
@NP	1 h	10781
@NP	room temperature	10788
@NP	24 h at 4 °C	10809
@NP	24 h	10809
@NP	4 °C	10817
@NP	several times	10830
@NP	PBS	10849
@NP	the red fluorescent-conjugated secondary antibody	10873
@NP	goat antimouse IgG , 1:200 , Sigma , Saint Louis , USA	10924
@NP	goat antimouse IgG	10924
@NP	1:200	10944
@NP	Sigma	10950
@NP	Saint Louis	10957
@NP	USA	10970
@NP	2 h	10979
@NP	room temperature	10986
@NP	the sections	11013
@NP	Aqua Poly/Mount -LRB- Polyscience , Warrington , PA , USA -RRB-	11066
@NP	Aqua Poly/Mount	11066
@NP	Polyscience , Warrington	11083
@NP	PA	11108
@NP	USA	11112
@NP	Control sections	11118
@NP	the test batch	11169
@NP	the primary antibody	11190
@NP	sections	11237
@NP	Olympus BX50 light microscope	11281
@NP	Images	11312
@NP	a DP71CCD camera/software	11339
@NP	Adobe Photoshop 10.0	11381
@NP	the measurement of the areas of GFAP and NF	11407
@NP	the measurement	11407
@NP	the areas of GFAP and NF	11426
@NP	the areas	11426
@NP	GFAP and NF	11439
@NP	injured area containing both transplanted cells and GFAP or NF reaction	11452
@NP	injured area	11452
@NP	transplanted cells and GFAP or NF reaction	11481
@NP	transplanted cells	11481
@NP	GFAP or NF reaction	11504
@NP	20 × -LRB- 0.388 mm2 -RRB-	11545
@NP	20 ×	11545
@NP	0.388 mm2	11550
@NP	every fifth section	11566
@NP	a total of five sections from each animal	11591
@NP	a total	11591
@NP	five sections from each animal	11602
@NP	five sections	11602
@NP	each animal	11621
@NP	The proportion of the GFAP and NF positive areas within the field	11634
@NP	The proportion	11634
@NP	the GFAP and NF positive areas within the field	11652
@NP	the GFAP	11652
@NP	NF positive areas within the field	11665
@NP	NF positive areas	11665
@NP	the field	11690
@NP	a percentage of the field	11732
@NP	a percentage	11732
@NP	the field	11748
@NP	Behavioral	11759
@NP	the BBB locomotor rating scale	11784
@NP	Basso	11816
@NP	et al. 1995	11822
@NP	et al.	11822
@NP	1995	11829
@NP	all rats	11836
@NP	locomotor function	11861
@NP	two observers	11883
@NP	the treatment groups	11908
@NP	BBB testing	11930
@NP	1 week	11974
@NP	6 weeks	12022
@NP	CSEP Recording and Analysis	12052
@NP	6 weeks	12083
@NP	transplantation	12097
@NP	15 rats -LRB- n05 in each group -RRB-	12114
@NP	15 rats	12114
@NP	n05 in each group	12123
@NP	n05	12123
@NP	each group	12130
@NP	3 % sodium pentobarbiturate	12165
@NP	atropine sulfate -LRB- 0.8 mg/kg -RRB-	12235
@NP	atropine sulfate	12235
@NP	0.8 mg/kg	12253
@NP	tracheal secretions	12277
@NP	Both left and right sciatic nerves	12298
@NP	a bipolar platinum wire electrode	12368
@NP	positive current pulses of 10 mA magnitude	12407
@NP	positive current pulses	12407
@NP	10 mA magnitude	12434
@NP	0.25 ms duration	12451
@NP	0.25 ms	12451
@NP	duration	12459
@NP	1 Hz frequency	12473
@NP	CSEP	12489
@NP	a Neuropack -LRB- Nihon Kohden Co , Japan -RRB-	12515
@NP	a Neuropack	12515
@NP	Nihon Kohden Co	12528
@NP	Japan	12545
@NP	a monopolar silver-ball placed on the surface of the sensorimotor cortex	12557
@NP	a monopolar silver-ball	12557
@NP	the surface of the sensorimotor cortex	12591
@NP	the surface	12591
@NP	the sensorimotor cortex	12606
@NP	bregma − 2 mm , lateral 2 mm	12631
@NP	bregma −	12631
@NP	2 mm , lateral 2 mm	12639
@NP	2 mm	12639
@NP	lateral 2 mm	12644
@NP	2	12652
@NP	The effect of electrical stimulation on CSEP	12658
@NP	The effect	12658
@NP	electrical stimulation on CSEP	12672
@NP	electrical stimulation	12672
@NP	CSEP	12698
@NP	terms	12719
@NP	latency	12728
@NP	the time	12737
@NP	a stimulus and the response	12763
@NP	a stimulus	12763
@NP	the response	12778
@NP	it -LRB- millisecond -RRB- and amplitude and voltage from the wave top	12794
@NP	it -LRB- millisecond -RRB-	12794
@NP	it	12794
@NP	amplitude and voltage from the wave top	12815
@NP	amplitude and voltage	12815
@NP	the wave top	12842
@NP	the bottom -LRB- millivolt -RRB-	12858
@NP	the bottom	12858
@NP	millivolt	12870
@NP	potentials	12906
@NP	all subjects	12920
@NP	the spinal cords	12934
@NP	histological processing	12968
@NP	Statistical Analysis Comparison	12993
@NP	the migration and distribution of transplanted cells between the groups	13028
@NP	the migration and distribution	13028
@NP	transplanted cells between the groups	13062
@NP	transplanted cells	13062
@NP	the groups	13089
@NP	two-tailed Student 's t test	13120
@NP	two-tailed Student 's	13120
@NP	Mann -- Whitney test was applied to analyze the areas of GFAP and NF .	13149
@NP	Mann	13149
@NP	Whitney test	13154
@NP	the areas of GFAP and NF	13190
@NP	the areas	13190
@NP	GFAP and NF	13203
@NP	P values	13216
@NP	three digits and less than 0.05 regarded as significant	13241
@NP	three digits	13241
@NP	less than 0.05 regarded as significant	13258
@NP	less than 0.05	13258
@NP	the values between groups	13318
@NP	the values	13318
@NP	groups	13337
@NP	the standard error -LRB- SEM -RRB-	13345
@NP	the standard error	13345
@NP	SEM	13365
@NP	± value in the text	13402
@NP	± value	13402
@NP	the text	13412
@NP	SEM bars on graphs	13428
@NP	SEM bars	13428
@NP	graphs	13440
@NP	Results Fig. 1 Histological observation of SCs and OECs	13449
@NP	Results	13449
@NP	Fig.	13458
@NP	1 Histological observation of SCs and OECs	13463
@NP	1 Histological observation	13463
@NP	SCs and OECs	13493
@NP	the contused spinal cord	13522
@NP	the	13522
@NP	spinal cord	13535
@NP	SCs transplantation	13554
@NP	the myelinated axons	13575
@NP	groups	13603
@NP	light microscope -LRB- a -RRB-	13616
@NP	light microscope	13616
@NP	electron microscope	13644
@NP	the clusters of myelinated axons and SCs	13665
@NP	the clusters	13665
@NP	myelinated axons and SCs	13681
@NP	thin glial membrane -LRB- arrows -RRB-	13724
@NP	thin glial membrane	13724
@NP	arrows	13745
@NP	some hypertrophic astrocytes -LRB- c -RRB-	13771
@NP	some hypertrophic astrocytes	13771
@NP	c	13801
@NP	the cord	13808
@NP	OECs	13827
@NP	the myelinated axons	13833
@NP	the spinal cord tissue	13881
@NP	astrocytes	13908
@NP	heperplasia and hypertrophy	13935
@NP	light and electron microscope -LRB- b , d -RRB-	13969
@NP	light and electron microscope	13969
@NP	c A astrocyte , S Schwann cell , M myelinated axon .	14007
@NP	c A astrocyte	14007
@NP	S Schwann cell , M myelinated axon	14022
@NP	S Schwann cell	14022
@NP	M myelinated axon	14038
@NP	Scale bar	14057
@NP	a , b010 μm ; c , d02 μm	14068
@NP	b010 μm ; c	14071
@NP	b010 μm	14071
@NP	c	14080
@NP	Fig. 2 Immunoreaction of GFAP after SCs and OECs transplantion	14091
@NP	Fig. 2 Immunoreaction	14091
@NP	GFAP after SCs and OECs transplantion	14116
@NP	GFAP	14116
@NP	SCs and OECs transplantion	14127
@NP	the cord	14158
@NP	SCs	14177
@NP	GFAP expression	14182
@NP	a distinct astroglial border	14227
@NP	many branches penetrating into the injured area -LRB- a -RRB-	14261
@NP	many branches	14261
@NP	the injured area -LRB- a -RRB-	14292
@NP	the injured area	14292
@NP	the cord	14317
@NP	OECs	14336
@NP	astroglial prominences	14342
@NP	astroglial border	14380
@NP	b	14411
@NP	OECs	14420
@NP	astroglial tissue	14441
@NP	they	14460
@NP	-LRB- b1 -RRB- , but not SCs -LRB- a1 -RRB-	14482
@NP	-LRB- b1 -RRB-	14482
@NP	SCs -LRB- a1 -RRB-	14496
@NP	SCs	14496
@NP	a1	14501
@NP	Scale	14506
@NP	a , b00 .15 mm ; a1 , b1050	14517
@NP	b00 .15 mm ; a1	14520
@NP	b00 .15 mm	14520
@NP	a1	14531
@NP	μm Fig.	14541
@NP	3 Percentage	14550
@NP	GFAP area	14566
@NP	SCs and OECs transplantation	14582
@NP	SCs injection	14646
@NP	OECs injection	14665
@NP	p <	14682
@NP	p	14682
@NP	3 weeks	14704
@NP	p	14714
@NP	0.05	14716
@NP	the groups Fig.	14738
@NP	4 The distribution and migration of SCs and OECs	14755
@NP	4 The distribution	14755
@NP	4	14755
@NP	The distribution	14757
@NP	migration of SCs and OECs	14778
@NP	migration	14778
@NP	SCs and OECs	14791
@NP	the contused spinal cord	14807
@NP	the	14807
@NP	spinal cord	14820
@NP	SCs	14833
@NP	a shorter migration distance in the injured area	14864
@NP	a shorter migration distance	14864
@NP	the injured area	14896
@NP	that	14922
@NP	OECs	14930
@NP	the normal tissue	14962
@NP	the injured area	14988
@NP	b	15006
@NP	distribution and migration of OECs	15030
@NP	distribution and migration	15030
@NP	OECs	15060
@NP	that of SCs -LRB- c , d -RRB-	15105
@NP	that	15105
@NP	SCs -LRB- c , d -RRB-	15113
@NP	SCs	15113
@NP	Scale bar : a , b00 .15 mm .	15125
@NP	Scale bar	15125
@NP	a , b00 .15 mm	15136
@NP	a	15136
@NP	b00 .15 mm	15139
@NP	* p < 0.05 compared with 3 weeks , + p <	15150
@NP	* p < 0.05	15150
@NP	p <	15151
@NP	p	15151
@NP	<	15152
@NP	0.05	15153
@NP	3 weeks , + p <	15172
@NP	3 weeks	15172
@NP	p <	15182
@NP	p	15182
@NP	the groups	15206
@NP	Fig. 5 Immunoreaction of NF after SCs and OECs transplantion	15218
@NP	Fig. 5 Immunoreaction	15218
@NP	NF after SCs and OECs transplantion	15243
@NP	NF	15243
@NP	SCs and OECs transplantion	15252
@NP	Both donor cells	15280
@NP	the axons labeled by NF immunoreaction	15310
@NP	the axons	15310
@NP	NF immunoreaction	15331
@NP	the injured area	15366
@NP	NF immunoreactive axons	15403
@NP	number and thicker in diameter in OECs group -LRB- b -RRB-	15439
@NP	number	15439
@NP	thicker in diameter in OECs group -LRB- b -RRB-	15450
@NP	thicker	15450
@NP	diameter in OECs group -LRB- b -RRB-	15461
@NP	diameter in OECs group	15461
@NP	OECs	15473
@NP	b	15485
@NP	SCs group	15496
@NP	-LRB- a -RRB- , which is further showed by the enlargers -LRB- c , d -RRB-	15506
@NP	-LRB- a -RRB- , which is further showed by the enlargers	15506
@NP	the enlargers	15538
@NP	Scale bar	15560
@NP	a , b0200 μm ; c , d030 μm	15571
@NP	b0200 μm ; c	15574
@NP	b0200 μm	15574
@NP	c	15584
@NP	Fig. 6 Percentage of NF area after SCs and OECs transplantation	15596
@NP	Fig. 6 Percentage	15596
@NP	NF area after SCs and OECs transplantation	15617
@NP	NF area	15617
@NP	SCs and OECs transplantation	15631
@NP	it	15670
@NP	SCs group	15688
@NP	OECs group	15706
@NP	no significant differences between the groups	15718
@NP	no significant differences	15718
@NP	the groups	15753
@NP	the statistical analysis	15780
@NP	p	15807
@NP	3 weeks Fig.	15828
@NP	7 BBB scores and CSEP after SCs and OECs transplantation	15842
@NP	7 BBB scores and CSEP	15842
@NP	SCs and OECs transplantation	15870
@NP	Both SCs and OECs	15900
@NP	locomotor function	15932
@NP	the 6-week recovery period	15958
@NP	toDMEM	15994
@NP	CSEP	16005
@NP	cell-inject groups	16036
@NP	the sixth week	16058
@NP	transplantation -LRB- b -RRB-	16079
@NP	transplantation	16079
@NP	b	16096
@NP	the amplitude	16104
@NP	the latency	16136
@NP	the normal group	16174
@NP	they	16201
@NP	DMEM group -LRB- c , d -RRB-	16246
@NP	DMEM group	16246
@NP	p	16266
@NP	0.01 compared with the control -LRB- DMEM -RRB- group , + p < 0.01	16268
@NP	0.01	16268
@NP	the control -LRB- DMEM -RRB- group , + p < 0.01	16287
@NP	the control -LRB- DMEM -RRB- group	16287
@NP	the control	16287
@NP	DMEM	16300
@NP	group	16306
@NP	p < 0.01	16314
@NP	p <	16314
@NP	p	16314
@NP	0.01	16316
@NP	normal group SCs Differ	16335
@NP	OECs	16365
@NP	the Reaction of Astrocytes in Morphology Following the injection of SCs and OECs	16373
@NP	the Reaction	16373
@NP	Astrocytes in Morphology Following the injection of SCs and OECs	16389
@NP	Astrocytes	16389
@NP	Morphology Following the injection of SCs and OECs	16403
@NP	Morphology	16403
@NP	the injection of SCs and OECs	16424
@NP	the injection	16424
@NP	SCs and OECs	16441
@NP	the contused spinal cord at the T10 spinal level	16459
@NP	the	16459
@NP	spinal cord	16472
@NP	the T10 spinal level	16487
@NP	the astrocytes	16509
@NP	different extent	16542
@NP	the transplanted cells	16562
@NP	the cords	16592
@NP	SCs	16611
@NP	the astrocytes	16616
@NP	larger	16655
@NP	their cell body	16665
@NP	the myelinated axons	16687
@NP	groups	16728
@NP	the glial membrane -LRB- Fig. 1a -RRB-	16738
@NP	the glial membrane	16738
@NP	Fig. 1a	16758
@NP	These features	16768
@NP	the ultrastructural level	16812
@NP	clusters of SCs	16845
@NP	clusters	16845
@NP	SCs	16857
@NP	a thin glial membrane	16879
@NP	myelinated axons	16905
@NP	some hypertrophic astrocytes -LRB- Fig. 1c -RRB-	16941
@NP	some hypertrophic astrocytes	16941
@NP	Fig. 1c	16971
@NP	contrast with SCs transplantation	16984
@NP	contrast	16984
@NP	SCs transplantation	16998
@NP	a number of mylinated axons	17029
@NP	a number	17029
@NP	mylinated axons	17041
@NP	both light and electron microscopes	17072
@NP	OECs	17109
@NP	hyperplasia and hypertrophy of astrocytes	17131
@NP	hyperplasia and hypertrophy	17131
@NP	astrocytes	17162
@NP	a plenty of glial tissue -LRB- Fig. 1b , d -RRB-	17187
@NP	a plenty	17187
@NP	glial tissue -LRB- Fig. 1b , d -RRB-	17199
@NP	glial tissue	17199
@NP	Fig. 1b , d	17213
@NP	Fig. 1b	17213
@NP	d	17222
@NP	SCs	17226
@NP	More	17237
@NP	GFAP Immunoreactivity	17251
@NP	OECs	17278
@NP	the host astrocytes response following the injections of SCs and OECs	17305
@NP	the host astrocytes response	17305
@NP	the injections of SCs and OECs	17344
@NP	the injections	17344
@NP	SCs and OECs	17362
@NP	cryostat sections	17376
@NP	GFAP	17417
@NP	a reliable marker widely used for detecting astrocytic responses to injury	17423
@NP	a reliable marker	17423
@NP	astrocytic responses	17467
@NP	injury	17491
@NP	It	17499
@NP	more enhanced GFAP expression	17519
@NP	more	17519
@NP	GFAP expression	17533
@NP	SCs injection	17568
@NP	a distinct astroglial border	17591
@NP	many prominences or branches penetrating into the injured area	17625
@NP	many prominences or branches	17625
@NP	the injured area	17671
@NP	a blurred astroglial border	17701
@NP	fewer penetrations after OECs injection -LRB- Fig. 2a , b -RRB-	17734
@NP	fewer penetrations	17734
@NP	OECs injection -LRB- Fig. 2a , b -RRB-	17759
@NP	OECs injection	17759
@NP	Fig. 2a , b	17775
@NP	Fig. 2a	17775
@NP	b	17784
@NP	OECs	17803
@NP	astroglial tissue while SCs can not -LRB- Fig. 2a1 , b1 -RRB-	17833
@NP	astroglial tissue	17833
@NP	SCs	17857
@NP	Fig. 2a1 , b1	17869
@NP	Fig. 2a1	17869
@NP	b1	17879
@NP	the area of GFAP immunoreactivity	17896
@NP	the area	17896
@NP	GFAP immunoreactivity	17908
@NP	SCs injection	17950
@NP	there	17965
@NP	GFAP areas of 23.71 % and 28.24 % at 3 and 6 weeks	17976
@NP	GFAP areas of 23.71 %	17976
@NP	GFAP areas	17976
@NP	23.71 %	17990
@NP	28.24 % at 3 and 6 weeks	18002
@NP	28.24 %	18002
@NP	at 3 and 6 weeks	18010
@NP	more than 17.76 %	18042
@NP	24.53 % after OECs injection -LRB- p < 0.05 -RRB- -LRB- Fig. 3 -RRB-	18064
@NP	24.53 %	18064
@NP	OECs injection -LRB- p < 0.05 -RRB- -LRB- Fig. 3 -RRB-	18078
@NP	OECs injection -LRB- p < 0.05 -RRB-	18078
@NP	OECs injection	18078
@NP	p < 0.05	18094
@NP	p	18094
@NP	< 0.05	18095
@NP	<	18095
@NP	0.05	18096
@NP	Fig. 3	18103
@NP	The Distribution	18112
@NP	Migration Differ	18133
@NP	SCs and OECs Transplantation The distribution and migration of SCs and OECs	18160
@NP	SCs and OECs Transplantation The distribution	18160
@NP	SCs and OECs	18160
@NP	The distribution	18189
@NP	migration of SCs and OECs	18210
@NP	migration	18210
@NP	SCs and OECs	18223
@NP	3 and 6 weeks following transplantation	18253
@NP	3 and 6 weeks	18253
@NP	transplantation	18277
@NP	Both donor cells	18294
@NP	the injured area at 3 weeks -LRB- Fig. 4a , b -RRB-	18339
@NP	the injured area	18339
@NP	3 weeks -LRB- Fig. 4a , b -RRB-	18359
@NP	3 weeks	18359
@NP	Fig. 4a , b	18368
@NP	Fig. 4a	18368
@NP	b	18377
@NP	6 weeks -LRB- Fig. 5a , b -RRB-	18401
@NP	6 weeks	18401
@NP	Fig. 5a , b	18410
@NP	Fig. 5a	18410
@NP	b	18419
@NP	the distribution of SCs	18432
@NP	the distribution	18432
@NP	SCs	18452
@NP	that of OECs in the contused spinal cord	18483
@NP	that	18483
@NP	OECs in the contused spinal cord	18491
@NP	OECs	18491
@NP	the contused spinal cord	18499
@NP	the	18499
@NP	spinal cord	18512
@NP	both donor cells	18535
@NP	the cord	18584
@NP	SCs	18598
@NP	shorter distance	18611
@NP	the normal tissue	18655
@NP	OECs	18686
@NP	distance	18712
@NP	a few cells	18725
@NP	the normal tissue	18751
@NP	Quantification of the distribution and migration	18770
@NP	Quantification	18770
@NP	the distribution and migration	18788
@NP	3 weeks	18834
@NP	the area of the distribution	18843
@NP	the area	18843
@NP	the distribution	18855
@NP	1.51 ±	18876
@NP	0.45 mm2 with a distance of 3.23 ±	18881
@NP	0.45 mm2	18881
@NP	a distance of 3.23 ±	18895
@NP	a distance	18895
@NP	3.23 ±	18909
@NP	0.53 mm	18914
@NP	the SCs group	18925
@NP	1.82 ±	18979
@NP	0.38 mm2 with a distance of 4.91 ± 0.58 mm	18984
@NP	0.38 mm2	18984
@NP	a distance of 4.91 ± 0.58 mm	18998
@NP	a distance	18998
@NP	4.91 ± 0.58 mm	19012
@NP	4.91 ±	19012
@NP	0.58 mm	19018
@NP	the OECs group -LRB- p < 0.05 -RRB-	19029
@NP	the OECs group	19029
@NP	p < 0.05	19045
@NP	p	19045
@NP	< 0.05	19046
@NP	<	19046
@NP	0.05	19047
@NP	the animals	19059
@NP	the cells	19082
@NP	the parameters	19137
@NP	1.99 ±	19165
@NP	0.49 mm2 with a distance of 5.23 ± 0.51 mm in the SCs group and 2.73 ± 0.53 mm2	19170
@NP	0.49 mm2	19170
@NP	a distance of 5.23 ± 0.51 mm in the SCs group and 2.73 ± 0.53 mm2	19184
@NP	a distance	19184
@NP	5.23 ± 0.51 mm in the SCs group and 2.73 ± 0.53 mm2	19198
@NP	0.51 mm in the SCs group	19203
@NP	0.51 mm	19203
@NP	the SCs group	19214
@NP	2.73 ± 0.53 mm2	19232
@NP	2.73 ±	19232
@NP	0.53 mm2	19237
@NP	a distance of 6.43 ±	19251
@NP	a distance	19251
@NP	6.43 ±	19265
@NP	0.43 mm in the OECs group	19270
@NP	0.43 mm	19270
@NP	the OECs group	19281
@NP	the sixth week	19299
@NP	the difference	19335
@NP	significant -LRB- p < 0.05 -RRB- -LRB- Fig. 4c , d -RRB-	19354
@NP	significant -LRB- p < 0.05 -RRB-	19354
@NP	significant	19354
@NP	p < 0.05	19367
@NP	p	19367
@NP	< 0.05	19368
@NP	<	19368
@NP	0.05	19369
@NP	Fig. 4c , d	19376
@NP	Fig. 4c	19376
@NP	d	19385
@NP	SCs and OECs	19389
@NP	Similar Changes	19409
@NP	NF Immunoreactivity	19428
@NP	At 3 and 6 weeks	19448
@NP	cell injection , both SCs and OECs	19471
@NP	cell injection	19471
@NP	SCs	19492
@NP	OECs	19500
@NP	morphologies	19537
@NP	the axons labeled by the NF immunoreaction to grow toward to the injured area	19564
@NP	the axons	19564
@NP	the NF immunoreaction	19585
@NP	the injured area	19625
@NP	Most of the regenerating axons	19643
@NP	Most	19643
@NP	the regenerating axons	19651
@NP	the main axis	19714
@NP	axons	19742
@NP	a few donor cells	19755
@NP	the axons -LRB- Fig. 5a -- d -RRB-	19791
@NP	the axons	19791
@NP	Fig. 5a -- d	19802
@NP	Fig. 5a	19802
@NP	d	19810
@NP	Qualitative observation	19814
@NP	the number of NF immunoreactive axons	19850
@NP	the number	19850
@NP	NF immunoreactive axons	19864
@NP	the OECs group	19900
@NP	the SCs group	19923
@NP	the area of NF immunoreactivity	19973
@NP	the area	19973
@NP	NF immunoreactivity	19985
@NP	a percentage	20014
@NP	10.46 % and 14.74 % in the SCs receiving animals	20030
@NP	10.46 % and 14.74 %	20030
@NP	the SCs	20053
@NP	animals	20071
@NP	11.55 % and 16.23 %	20083
@NP	the OECs	20106
@NP	animals	20125
@NP	3 and 6 weeks , respectively	20136
@NP	3 and 6 weeks	20136
@NP	the area of NF	20174
@NP	the area	20174
@NP	NF	20186
@NP	6 weeks than at 3 weeks	20203
@NP	6 weeks	20203
@NP	each group	20234
@NP	no significant differences between the groups	20246
@NP	no significant differences	20246
@NP	the groups	20281
@NP	the statistical analysis -LRB- Fig. 6 -RRB-	20309
@NP	the statistical analysis	20309
@NP	Fig. 6	20335
@NP	SCs and OECs	20344
@NP	Locomotor Performance and CSEP of the Transplanted Rats All animals	20365
@NP	Locomotor Performance and CSEP	20365
@NP	the Transplanted Rats All animals	20399
@NP	gradual improvements	20443
@NP	hind limb locomotor function	20467
@NP	the 6-week recovery period	20503
@NP	One week	20531
@NP	transplantation , BBB scores for SCs and OECs	20546
@NP	transplantation	20546
@NP	BBB scores for SCs and OECs	20563
@NP	BBB scores	20563
@NP	SCs and OECs	20578
@NP	transplanted rats	20591
@NP	6.82 ± 1.30 and 7.2 ± 1.27 respectively	20618
@NP	6.82 ± 1.30 and 7.2 ± 1.27	20618
@NP	3.25 ± 1.13 for DMEM injected rats	20667
@NP	3.25	20667
@NP	± 1.13 for DMEM	20671
@NP	± 1.13	20671
@NP	DMEM	20681
@NP	rats	20695
@NP	6 weeks	20704
@NP	SCs rats	20713
@NP	13.53 ±	20729
@NP	1.16 and OECs rats	20735
@NP	13.68 ± 1.20	20761
@NP	9.52 ± 0.95 for the DMEM rats	20785
@NP	9.52 ± 0.95	20785
@NP	the DMEM rats	20799
@NP	No significant difference between the SCs - and OECsinjected rats	20814
@NP	No significant difference	20814
@NP	the SCs - and OECsinjected rats	20848
@NP	the SCs	20848
@NP	OECsinjected rats	20861
@NP	the BBB scores of both groups	20916
@NP	the BBB scores	20916
@NP	both groups	20934
@NP	the controls -LRB- p < 0.01 -RRB- -LRB- Fig. 7a -RRB-	20974
@NP	the controls -LRB- p < 0.01 -RRB-	20974
@NP	the controls	20974
@NP	p < 0.01	20988
@NP	p	20988
@NP	< 0.01	20989
@NP	<	20989
@NP	0.01	20990
@NP	Fig. 7a	20997
@NP	the amplitude and the latency in the SCs and OECs groups	21544
@NP	the amplitude	21544
@NP	the latency in the SCs and OECs groups	21562
@NP	the latency	21562
@NP	the SCs and OECs groups	21577
@NP	the DMEM group -LRB- p < 0.01 -RRB- -LRB- Fig. 7c , d -RRB-	21635
@NP	the DMEM group -LRB- p < 0.01 -RRB-	21635
@NP	the DMEM group	21635
@NP	p < 0.01	21650
@NP	p	21650
@NP	< 0.01	21651
@NP	<	21651
@NP	0.01	21652
@NP	Fig. 7c , d	21659
@NP	Fig. 7c	21659
@NP	d	21668
@NP	Discussion The environment of the injured CNS	21673
@NP	Discussion The environment	21673
@NP	the injured CNS	21703
@NP	unfavorable	21722
@NP	axon regeneration	21738
@NP	a multiplicity	21760
@NP	reasons , foremost among which is the astrocytic response to injury	21778
@NP	reasons	21778
@NP	foremost among which is the astrocytic response to injury	21787
@NP	foremost	21787
@NP	the astrocytic response to injury	21811
@NP	the astrocytic response	21811
@NP	injury	21838
@NP	a strategy	21852
@NP	axon regeneration	21877
@NP	cells	21914
@NP	the inhibitory CNS glial environment	21942
@NP	many animal experiments	21996
@NP	The current study	22021
@NP	the behavior of SCs and OECs	22062
@NP	the behavior	22062
@NP	SCs and OECs	22078
@NP	astrocytes following implantation into the contused spinal cord	22111
@NP	astrocytes	22111
@NP	implantation into the contused spinal cord	22132
@NP	implantation	22132
@NP	the contused spinal cord	22150
@NP	the	22150
@NP	spinal cord	22163
@NP	the function	22189
@NP	the injured spinal cord	22205
@NP	either of SCs or OECs	22241
@NP	either	22241
@NP	SCs or OECs	22251
@NP	BBB score and CSEP recording	22269
@NP	BBB score	22269
@NP	CSEP recording	22283
@NP	Histological results	22299
@NP	the proliferation of astrocytes	22332
@NP	the proliferation	22332
@NP	astrocytes	22353
@NP	larger cell bodies and stronger expression of GFAG	22370
@NP	larger cell bodies	22370
@NP	stronger expression of GFAG	22393
@NP	stronger expression	22393
@NP	GFAG	22416
@NP	SCs cord	22444
@NP	OECs cord	22461
@NP	SCs	22485
@NP	a shorter distance accompanied by a smaller distribution area than OECs	22498
@NP	a shorter distance	22498
@NP	a smaller distribution area than OECs	22532
@NP	a smaller distribution area	22532
@NP	OECs	22565
@NP	the contused spinal cord	22577
@NP	the	22577
@NP	spinal cord	22590
@NP	both SCs and OECs	22612
@NP	NF positive axons	22643
@NP	axons	22697
@NP	GAP-43 immunoreaction -LRB- Andrews and Stelzner 2007 -RRB-	22727
@NP	GAP-43 immunoreaction	22727
@NP	Andrews and Stelzner 2007	22750
@NP	Andrews	22750
@NP	Stelzner 2007	22762
@NP	the injured area	22797
@NP	Electrophysiological and behavioral results	22815
@NP	the grafts of either SCs or OECs	22871
@NP	the grafts	22871
@NP	either SCs or OECs	22885
@NP	the function of the contused spinal cord at 6 weeks after transplantation	22918
@NP	the function	22918
@NP	the contused spinal cord at 6 weeks after transplantation	22934
@NP	the	22934
@NP	spinal cord	22947
@NP	6 weeks	22962
@NP	transplantation	22976
@NP	This	22993
@NP	accordance	23001
@NP	the observation in the photochemical injury spinal cord	23017
@NP	the observation	23017
@NP	the photochemical injury spinal cord	23036
@NP	both SCs and OECs	23082
@NP	SCs	23087
@NP	OECs	23095
@NP	potential for restoration of injured spinal cords	23104
@NP	potential	23104
@NP	restoration of injured spinal cords	23118
@NP	restoration	23118
@NP	injured spinal cords	23133
@NP	OECs grafts	23159
@NP	superior ability	23176
@NP	functional recovery -LRB- Garcia-Alias et al. 2004 -RRB-	23204
@NP	functional recovery	23204
@NP	Garcia-Alias	23225
@NP	et al. 2004	23238
@NP	et al.	23238
@NP	2004	23245
@NP	it	23264
@NP	assays	23299
@NP	the interactions between astrocytes	23316
@NP	the interactions	23316
@NP	astrocytes	23341
@NP	SCs or OECs	23363
@NP	astrocytes and SCs	23376
@NP	nonoverlapping domains	23418
@NP	astrocytes and OECs	23450
@NP	co-culture -LRB- Lakatos et al. 2000 ; Fairless et al. 2005 -RRB-	23492
@NP	co-culture	23492
@NP	Lakatos	23504
@NP	et al. 2000 ; Fairless et al. 2005	23512
@NP	et al. 2000 ; Fairless et al.	23512
@NP	et al. 2000	23512
@NP	et al.	23512
@NP	2000	23519
@NP	Fairless et al.	23525
@NP	Fairless	23525
@NP	et al.	23534
@NP	2005	23541
@NP	Astrocytes	23548
@NP	hypertrophy when	23567
@NP	hypertrophy	23567
@NP	contact with SCs	23587
@NP	contact	23587
@NP	SCs	23600
@NP	OECs	23617
@NP	SCs	23623
@NP	a poor capacity to migrate within astrocyte-rich areas	23635
@NP	astrocyte-rich areas	23669
@NP	contrast to SCs	23694
@NP	contrast	23694
@NP	SCs	23706
@NP	OECs	23711
@NP	astrocytes	23758
@NP	astrocytes within the olfactory system -LRB- Doucette 1993 -RRB-	23827
@NP	astrocytes	23827
@NP	the olfactory system -LRB- Doucette 1993 -RRB-	23845
@NP	the olfactory system	23845
@NP	Doucette 1993	23867
@NP	vivo studies	23889
@NP	it	23903
@NP	SCs	23926
@NP	more host astrocyte response	23937
@NP	GFAP and chondroitin sulphate proteoglycan -LRB- CSPG -RRB-	23970
@NP	GFAP and chondroitin sulphate proteoglycan	23970
@NP	CSPG	24014
@NP	an inhibitory molecule	24021
@NP	axon regeneration	24047
@NP	Fawcet and Asher 1999 ; Plant et al. 2001	24066
@NP	Fawcet and Asher 1999 ; Plant et al.	24066
@NP	Fawcet and Asher 1999	24066
@NP	Fawcet	24066
@NP	Asher 1999	24077
@NP	Plant et al.	24089
@NP	Plant	24089
@NP	et al.	24095
@NP	2001	24102
@NP	expression	24109
@NP	OECs following transplantation into white matter of rat spinal cord	24125
@NP	OECs	24125
@NP	transplantation into white matter of rat spinal cord	24140
@NP	transplantation	24140
@NP	white matter of rat spinal cord	24161
@NP	white matter	24161
@NP	rat spinal cord	24177
@NP	Lakatos	24194
@NP	et al. 2000	24202
@NP	et al.	24202
@NP	2000	24209
@NP	the mechanism of different interactions between SCs and OECs with astrocytes	24229
@NP	the mechanism	24229
@NP	different interactions between SCs and OECs with astrocytes	24246
@NP	different interactions	24246
@NP	SCs and OECs with astrocytes	24277
@NP	SCs and OECs	24277
@NP	astrocytes	24295
@NP	assays	24348
@NP	N-cadherin	24376
@NP	the adhesion and migration of SCs and OECs	24402
@NP	the adhesion and migration	24402
@NP	SCs and OECs	24432
@NP	astrocytes -LRB- Wilby et al. 1999 ; Fairless et al. 2005 -RRB-	24466
@NP	astrocytes	24466
@NP	Wilby	24478
@NP	et al. 1999 ; Fairless et al. 2005	24484
@NP	et al. 1999 ; Fairless et al.	24484
@NP	et al. 1999	24484
@NP	et al.	24484
@NP	1999	24491
@NP	Fairless et al.	24497
@NP	Fairless	24497
@NP	et al.	24506
@NP	2005	24513
@NP	N-cadherin , a predominant member of the cadherin family ,	24520
@NP	N-cadherin	24520
@NP	a predominant member of the cadherin family	24532
@NP	a predominant member	24532
@NP	the cadherin family	24556
@NP	an important role in axonal guidance -LRB- Ranscht 2000 -RRB-	24583
@NP	an important role	24583
@NP	axonal guidance -LRB- Ranscht 2000 -RRB-	24604
@NP	axonal guidance	24604
@NP	Ranscht 2000	24621
@NP	development	24643
@NP	N-cadherin	24656
@NP	important roles in neurulation -LRB- Takeichi et al. 1990 -RRB-	24671
@NP	important roles	24671
@NP	neurulation -LRB- Takeichi et al. 1990 -RRB-	24690
@NP	neurulation	24690
@NP	Takeichi	24703
@NP	et al. 1990	24712
@NP	et al.	24712
@NP	1990	24719
@NP	Cadherins	24726
@NP	calciumdependent adhesion molecules	24740
@NP	cadherin molecules	24793
@NP	adjacent cells	24815
@NP	adherent junctions between cells -LRB- Wanner and Wood 2002 -RRB-	24839
@NP	adherent junctions	24839
@NP	cells -LRB- Wanner and Wood 2002 -RRB-	24866
@NP	cells	24866
@NP	Wanner and Wood 2002	24873
@NP	Wanner	24873
@NP	Wood 2002	24884
@NP	This peptide	24896
@NP	adhesion between cells	24928
@NP	adhesion	24928
@NP	cells	24945
@NP	intracellular signaling cascades	24978
@NP	neurite outgrowth	25022
@NP	Bixby and Zhang 1990 ; Kiryushko et al. 2004	25041
@NP	Bixby and Zhang 1990 ; Kiryushko et al.	25041
@NP	Bixby and Zhang 1990	25041
@NP	Bixby	25041
@NP	Zhang 1990	25051
@NP	Kiryushko et al.	25063
@NP	Kiryushko	25063
@NP	et al.	25073
@NP	2004	25080
@NP	synaptic plasticity	25090
@NP	Fannon and Colman 1996 ; Uchida et al. 1996 ; Bruses 2000	25111
@NP	Fannon and Colman 1996	25111
@NP	Fannon	25111
@NP	Colman 1996	25122
@NP	Uchida et al. 1996	25135
@NP	Uchida	25135
@NP	et al.	25142
@NP	1996	25149
@NP	Bruses 2000	25155
@NP	Bruses	25155
@NP	2000	25162
@NP	Silencing N-cadherin using siRNA	25169
@NP	Silencing N-cadherin	25169
@NP	siRNA	25196
@NP	distinct biological effects on the interactions of SCs and OECs	25206
@NP	distinct biological effects	25206
@NP	the interactions of SCs and OECs	25237
@NP	the interactions	25237
@NP	SCs and OECs	25257
@NP	astrocytes	25275
@NP	co-culture of SCs and astrocytes	25290
@NP	co-culture	25290
@NP	SCs and astrocytes	25304
@NP	suppression of N-cadherin	25324
@NP	suppression	25324
@NP	N-cadherin	25339
@NP	heterotypic and homotypic adhesion	25358
@NP	they	25397
@NP	adhesion properties	25409
@NP	OECs	25442
@NP	contrast	25451
@NP	N-cad siRNA transfection into OECs	25461
@NP	N-cad siRNA transfection	25461
@NP	OECs	25491
@NP	little effect on their migration and adhesion	25500
@NP	little effect	25500
@NP	their migration and adhesion	25517
@NP	astrocytes	25565
@NP	These findings	25577
@NP	N-cadherin	25603
@NP	SCs and OECs -LRB- Fairless , et al. 2005 -RRB-	25645
@NP	SCs and OECs	25645
@NP	Fairless , et al. 2005	25659
@NP	Fairless , et al.	25659
@NP	Fairless	25659
@NP	et al.	25669
@NP	2005	25676
@NP	translocation	25705
@NP	nuclear factor kappa B , a key transcriptional regulator of inflammatory genes ,	25722
@NP	nuclear factor kappa B	25722
@NP	a key transcriptional regulator of inflammatory genes	25746
@NP	a key transcriptional regulator	25746
@NP	inflammatory genes	25781
@NP	astrocyte nuclei	25804
@NP	OECs releasing insulin-like growth factor-1	25824
@NP	OECs	25824
@NP	insulin-like growth factor-1	25839
@NP	one	25876
@NP	the reasons	25883
@NP	different reactions	25906
@NP	SCs andOECs with astrocytes -LRB- Hale et al. 2011 -RRB-	25934
@NP	SCs andOECs	25934
@NP	astrocytes -LRB- Hale et al. 2011 -RRB-	25951
@NP	astrocytes	25951
@NP	Hale	25963
@NP	et al. 2011	25968
@NP	et al.	25968
@NP	2011	25975
@NP	the previous studies	25985
@NP	it	26007
@NP	SCs	26034
@NP	OECs	26060
@NP	transplant-mediated repair of injured spinal cord	26069
@NP	transplant-mediated repair	26069
@NP	injured spinal cord	26099
@NP	the different interactions of SCs and OECs	26129
@NP	the different interactions	26129
@NP	SCs and OECs	26159
@NP	astrocytes and biological behavior	26177
@NP	astrocytes	26177
@NP	biological behavior	26192
@NP	transplantation -LRB- Lakatos et al. 2000 , 2003 ; Fairless et al. 2005 -RRB-	26218
@NP	transplantation	26218
@NP	Lakatos	26235
@NP	et al. 2000 , 2003 ; Fairless et al. 2005	26243
@NP	et al.	26243
@NP	2000 , 2003 ; Fairless et al. 2005	26250
@NP	2000 , 2003	26250
@NP	2000	26250
@NP	2003	26256
@NP	Fairless et al. 2005	26262
@NP	Fairless	26262
@NP	et al.	26271
@NP	2005	26278
@NP	SCs	26293
@NP	astrocytes	26305
@NP	more	26325
@NP	more	26355
@NP	OECs	26373
@NP	transplantation	26388
@NP	the present study	26419
@NP	both cells	26442
@NP	the axons	26467
@NP	the injured regions	26501
@NP	the function	26533
@NP	the contused spinal cords demonstrated by BBB score and CSEP recording	26549
@NP	the	26549
@NP	spinal cords demonstrated by BBB score and CSEP recording	26562
@NP	spinal cords	26562
@NP	BBB score and CSEP recording	26591
@NP	BBB score	26591
@NP	CSEP recording	26605
@NP	the data of either BBB score or CSEP recording	26630
@NP	the data	26630
@NP	either BBB score or CSEP recording	26642
@NP	BBB score	26649
@NP	CSEP recording	26662
@NP	recovery of the function in the SCs group	26689
@NP	recovery	26689
@NP	the function in the SCs group	26701
@NP	the function	26701
@NP	the SCs group	26717
@NP	that in the OECs group	26751
@NP	that	26751
@NP	the OECs group	26759
@NP	no statistical difference	26775
@NP	the groups	26827
@NP	SCs	26853
@NP	cell-mediated repair	26880
@NP	Previous studies	26902
@NP	both SCs and OECs	26952
@NP	SCs	26957
@NP	OECs	26965
@NP	the structure and function of the injured spinal cord	26982
@NP	the structure and function	26982
@NP	the injured spinal cord	27012
@NP	review	27041
@NP	Bunge 2008 ; Kocsis et al. 2009	27053
@NP	Bunge 2008	27053
@NP	Kocsis et al. 2009	27065
@NP	Kocsis	27065
@NP	et al.	27072
@NP	2009	27079
@NP	the study	27096
@NP	Takami	27119
@NP	et al. -LRB- 2002 -RRB-	27126
@NP	et al.	27126
@NP	2002	27134
@NP	a SCs graft	27152
@NP	axonal sparing/regeneration	27195
@NP	hind limb locomotor performance	27240
@NP	a OECs graft in the moderately contused thoracic spinal cord	27277
@NP	a OECs graft	27277
@NP	the moderately contused thoracic spinal cord	27293
@NP	the chronic contusive spinal cord	27342
@NP	the transplanted SCs	27377
@NP	a substantive graft within the injury site	27403
@NP	a substantive graft	27403
@NP	the injury site	27430
@NP	the ingrowth of axons	27468
@NP	the ingrowth	27468
@NP	axons	27484
@NP	growth	27494
@NP	calcitonin generelated peptide-positive and supraspinal serotonergic axons	27519
@NP	calcitonin	27519
@NP	peptide-positive and supraspinal serotonergic axons	27542
@NP	corticospinal axon numbers	27609
@NP	the injury -- graft site	27659
@NP	the injury	27659
@NP	graft site	27670
@NP	SCs ' grafted animals	27692
@NP	SCs '	27692
@NP	modest improvements	27726
@NP	open field locomotion	27749
@NP	less foot position errors -LRB- Barakat et al. 2005 -RRB-	27785
@NP	less foot position errors	27785
@NP	Barakat	27812
@NP	et al. 2005	27820
@NP	et al.	27820
@NP	2005	27827
@NP	These regenerated axons induced by SCs ' transplantation	27834
@NP	These regenerated axons	27834
@NP	SCs ' transplantation	27869
@NP	SCs '	27869
@NP	measurable	27915
@NP	responses following electrical stimulation -LRB- Pinzon et al. 2001 -RRB-	27933
@NP	responses	27933
@NP	electrical stimulation -LRB- Pinzon et al. 2001 -RRB-	27953
@NP	electrical stimulation	27953
@NP	Pinzon	27977
@NP	et al. 2001	27984
@NP	et al.	27984
@NP	2001	27991
@NP	Such a restorative role for SCs	27998
@NP	Such a restorative role	27998
@NP	SCs	28026
@NP	their	28047
@NP	neurotrophic factors	28064
@NP	NGF -LRB- Bandtlow et al. 1987 -RRB-	28093
@NP	NGF	28093
@NP	Bandtlow	28098
@NP	et al. 1987	28107
@NP	et al.	28107
@NP	1987	28114
@NP	BDNF -LRB- Acheson et al. 1991 ; Meyer et al. 1992 -RRB-	28121
@NP	BDNF	28121
@NP	Acheson	28127
@NP	et al. 1991 ; Meyer et al. 1992	28135
@NP	et al. 1991 ; Meyer et al.	28135
@NP	et al. 1991	28135
@NP	et al.	28135
@NP	1991	28142
@NP	Meyer et al.	28148
@NP	Meyer	28148
@NP	et al.	28154
@NP	1992	28161
@NP	CNTF -LRB- Friedman et al. 1992 ; Rende et al. 1992 -RRB-	28168
@NP	CNTF	28168
@NP	Friedman	28174
@NP	et al. 1992 ; Rende et al. 1992	28183
@NP	et al. 1992 ; Rende et al.	28183
@NP	et al. 1992	28183
@NP	et al.	28183
@NP	1992	28190
@NP	Rende et al.	28196
@NP	Rende	28196
@NP	et al.	28202
@NP	1992	28209
@NP	GDNF -LRB- Widenfalk et al. 2001 -RRB-	28220
@NP	GDNF	28220
@NP	Widenfalk	28226
@NP	et al. 2001	28236
@NP	et al.	28236
@NP	2001	28243
@NP	the contiguous host cord	28273
@NP	the axon to regenerate and sprout	28310
@NP	SCs	28359
@NP	OECs	28364
@NP	BDNF	28377
@NP	NGF	28383
@NP	GDNF	28388
@NP	NT-4 / 5 -LRB- Woodhall et al. 2001 ; Boruch et al. 2001 -RRB-	28398
@NP	NT-4 / 5	28398
@NP	NT-4	28398
@NP	5	28403
@NP	Woodhall	28406
@NP	et al. 2001 ; Boruch et al. 2001	28415
@NP	et al. 2001 ; Boruch et al.	28415
@NP	et al. 2001	28415
@NP	et al.	28415
@NP	2001	28422
@NP	Boruch et al.	28428
@NP	Boruch	28428
@NP	et al.	28435
@NP	2001	28442
@NP	addition to the distribution and migration of the transplanted cells	28458
@NP	addition	28458
@NP	the distribution and migration of the transplanted cells	28470
@NP	the distribution and migration	28470
@NP	the transplanted cells	28504
@NP	neurotrophic factors released by them	28528
@NP	neurotrophic factors	28528
@NP	them	28561
@NP	the structure and function of the contused spinal cord	28592
@NP	the structure and function	28592
@NP	the contused spinal cord	28622
@NP	the	28622
@NP	spinal cord	28635
@NP	summary	28651
@NP	our results from the contusion SCI model	28660
@NP	our results	28660
@NP	the contusion SCI model	28677
@NP	the previous observations from the dorsal crush	28709
@NP	the previous observations	28709
@NP	the dorsal crush	28740
@NP	transection injury	28758
@NP	normal white matter	28782
@NP	the spinal cord	28805
@NP	graft	28830
@NP	host astrocyte response and GFAP expression compared to OECs graft	28849
@NP	host astrocyte response and GFAP expression	28849
@NP	OECs graft	28905
@NP	it	28926
@NP	SCs	28970
@NP	OECs	29020
@NP	the contused spinal cord	29032
@NP	the	29032
@NP	spinal cord	29045
@NP	the myelinated axons	29077
@NP	the groups	29118
@NP	the glial membrane in the SCs cord	29132
@NP	the glial membrane	29132
@NP	the SCs cord	29154
@NP	the OECs cord	29179
@NP	it	29206
@NP	the SCs group	29223
@NP	both SCs and OECs	29238
@NP	SCs	29243
@NP	OECs	29251
@NP	NF expression	29270
@NP	the function of the contused spinal cord	29296
@NP	the function	29296
@NP	the contused spinal cord	29312
@NP	the	29312
@NP	spinal cord	29325
@NP	SCs	29341
@NP	a valuable candidate for cell-mediated repair of the injured spinal cord	29361
@NP	a valuable candidate	29361
@NP	cell-mediated repair of the injured spinal cord	29386
@NP	cell-mediated repair	29386
@NP	the injured spinal cord	29410
@NP	maximal benefit	29455
@NP	the recovery of the injured spinal cord	29475
@NP	the recovery	29475
@NP	the injured spinal cord	29491
@NP	a combinative transplantation	29516
@NP	SCs and OECs	29549
@NP	some factors for promoting cell migration and axon regeneration	29567
@NP	some factors	29567
@NP	cell migration and axon regeneration	29594
@NP	cell migration	29594
@NP	axon regeneration	29613
@NP	the future	29654
@VP	Interacting with Astrocyte	73
@VP	interacting with astrocytes	351
@VP	was appraised qualitatively in vitro	379
@VP	appraised qualitatively in vitro	383
@VP	to select a candidate for cell-mediated repair of the spinal cord injury	539
@VP	select a candidate for cell-mediated repair of the spinal cord injury	542
@VP	were transplanted into contused spinal cord in adult rats	625
@VP	transplanted into contused spinal cord in adult rats	630
@VP	was appraised with the BBB locomotor rating scale	840
@VP	appraised with the BBB locomotor rating scale	844
@VP	evoked potentials -LRB- CSEP -RRB- recording	917
@VP	underwent proliferation and hypertrophy	985
@VP	were separated into the groups by the glial membrane	1047
@VP	separated into the groups by the glial membrane	1052
@VP	did not undergo the proliferation and hypertrophy	1130
@VP	undergo the proliferation and hypertrophy	1138
@VP	were not divided into groups by the scar tissue	1202
@VP	divided into groups by the scar tissue	1211
@VP	was more concentrated and less migrated than that of OECs	1464
@VP	was more concentrated	1464
@VP	less migrated than that of OECs	1490
@VP	induced weaker NF immunoreactivity and functional recovery compared to OECs	1527
@VP	was revealed by the statistical analysis	1658
@VP	revealed by the statistical analysis	1662
@VP	know	1706
@VP	is first time to compare behaviors of SCs and OECs in the contusion model	1717
@VP	to compare behaviors of SCs and OECs in the contusion model	1731
@VP	compare behaviors of SCs and OECs in the contusion model	1734
@VP	are different in interacting with astrocyte	1868
@VP	interacting with astrocyte	1885
@VP	can improve the motor function of the contused rats	1929
@VP	improve the motor function of the contused rats	1933
@VP	will cause glial scar	2070
@VP	cause glial scar	2075
@VP	activated in response to injury	2108
@VP	is thought to isolate necrotic tissue	2430
@VP	thought to isolate necrotic tissue	2433
@VP	to isolate necrotic tissue	2441
@VP	isolate necrotic tissue	2444
@VP	resulting from injury -LRB- Eddleston and Mucke 1993 -RRB-	2523
@VP	in vivo -LRB- Lakatos et al. 2003 ; Santos-Silva et al. 2007 -RRB-	3444
@VP	Using in vitro assays	3501
@VP	show that both SCs and OECs migrate across astrocyte monolayers	3523
@VP	migrate across astrocyte monolayers	3551
@VP	will migrate into an area containing astrocytes	3602
@VP	migrate into an area containing astrocytes	3607
@VP	containing astrocytes	3628
@VP	transplanted into the contused spinal cord	4035
@VP	contused spinal cord	4057
@VP	interacting with astrocyte and glial scar	4100
@VP	were appraised with semi-quantitative analysis and ultrastructural description	4142
@VP	appraised with semi-quantitative analysis and ultrastructural description	4147
@VP	was rated by the BBB locomotor rating scale	4275
@VP	rated by the BBB locomotor rating scale	4279
@VP	evoked potentials -LRB- CSEP -RRB- recording	4346
@VP	mingle with glial scar	4439
@VP	move more extensively than SCs through GFAP immunocytochemistry	4466
@VP	separated by collagen membrane	4569
@VP	accompanied by hypertrophic astrocytes	4604
@VP	did not	4659
@VP	could improve the motor function of contused rat spinal cord	4785
@VP	improve the motor function of contused rat spinal cord	4791
@VP	selecting candidate transplant cells in human SCI therapy in the future	4884
@VP	were removed from adult GFP rats	5057
@VP	removed from adult GFP rats	5062
@VP	were isolated using slightly modified method described in Lankford et al. 2002	5095
@VP	isolated using slightly modified method described in Lankford et al. 2002	5100
@VP	using slightly modified method described in Lankford et al. 2002	5109
@VP	described in Lankford et al.	5140
@VP	followed by 15 min in 0.5 mg/ml trypsin -LRB- Worthington , Lakewood , NJ -RRB-	5343
@VP	mechanically triturated with fire polished pipettes	5415
@VP	filtering the cell suspension with a 70-μm cell strainer -LRB- Falcon -RRB-	5506
@VP	were isolated as described in detail in Sasaki et al. 2004	5578
@VP	isolated as described in detail in Sasaki et al. 2004	5583
@VP	described in detail in Sasaki et al. 2004	5595
@VP	dissected free of meninges and white matter	5696
@VP	minced with scalpel blades	5741
@VP	dissociated with very gentle mechanical trituration	6025
@VP	washed	6078
@VP	removing and washing nonadherent cells	6152
@VP	concentrating to 30,000 cells per microliter	6245
@VP	washed and plated on poly-L-lysine coated chamber slides	6335
@VP	cultured in DMEM with 10 % FCS and penicillin/streptomycin	6396
@VP	fixed with ice-cold methanol	6487
@VP	stain	6879
@VP	showed that at least 95 % of donor cells were both P75 and S-100 positive	6917
@VP	were both P75 and S-100 positive	6958
@VP	approved by TMMU Institutional Animal Care and Use Committee	7224
@VP	was performed at vertebral levels T10 without disrupting the dura	7421
@VP	performed at vertebral levels T10 without disrupting the dura	7425
@VP	disrupting the dura	7467
@VP	were closed in layers	7664
@VP	closed in layers	7669
@VP	resulted in hind limb paralysis in all animals	7701
@VP	To prevent wound and bladder infections	7749
@VP	prevent wound and bladder infections	7752
@VP	performed twice daily for 7 days after contusion	7870
@VP	were reanesthetized	7999
@VP	reanesthetized	8004
@VP	were re-exposed at the same site	8033
@VP	re-exposed at the same site	8038
@VP	contused cord at a depth of 0.8 mm at the epicenter of the lesion	8136
@VP	was used	8287
@VP	used	8291
@VP	remained in place for 5 min after each injection	8372
@VP	were injected at identical volumes of DMEM at the same sites	8442
@VP	injected at identical volumes of DMEM at the same sites	8447
@VP	were closed with interrupted sutures	8545
@VP	closed with interrupted sutures	8550
@VP	was 3 weeks -LRB- n015 -RRB- and 6 weeks -LRB- n015 -RRB-	8616
@VP	removed	8983
@VP	cut at a thickness of 15 μm on a LEICA Cryostat	9152
@VP	dried on a heating plate	9201
@VP	mounted with Aqua Poly / Mount -LRB- Polyscience , Inc. -RRB-	9230
@VP	examined using Olympus fluorescence microscope	9299
@VP	using Olympus fluorescence microscope	9308
@VP	photographed with DP71 digital camera and software	9350
@VP	fluoresce only in the green wavelength	9532
@VP	collected at 20 ×	9647
@VP	to facilitate measurements of cell distribution without duplication	9704
@VP	facilitate measurements of cell distribution without duplication	9707
@VP	to measure the distribution and migration of SCs and OECs in the contused cord	9800
@VP	measure the distribution and migration of SCs and OECs in the contused cord	9803
@VP	contused cord	9865
@VP	were collected from osmicated , dehydrated , and embedded tissue blocks	9922
@VP	collected from osmicated , dehydrated , and embedded tissue blocks	9927
@VP	osmicated , dehydrated , and embedded tissue blocks	9942
@VP	osmicated , dehydrated ,	9942
@VP	embedded tissue blocks	9969
@VP	stained with methylene blue/Azure II	10007
@VP	observed for the lesion and location under Olympus BX50 microscope	10048
@VP	cut from the tissue blocks embedded plastically	10155
@VP	blocks embedded plastically	10175
@VP	counterstained with uranyl and lead salts	10204
@VP	counterstained with uranyl	10204
@VP	lead salts	10235
@VP	examined with a TECNT 10 electron microscope -LRB- Netherlands -RRB-	10251
@VP	rinsed in PBS for 30 min	10414
@VP	washed several times with PBS	10823
@VP	included with the test batch where the primary antibody was absent	11155
@VP	was absent	11211
@VP	Immunostained	11223
@VP	were observed and quantified under Olympus BX50 light microscope	11246
@VP	observed and quantified under Olympus BX50 light microscope	11251
@VP	captured using a DP71CCD camera/software and montaged by Adobe Photoshop 10.0	11324
@VP	captured using a DP71CCD camera/software	11324
@VP	using a DP71CCD camera/software	11333
@VP	montaged by Adobe Photoshop 10.0	11369
@VP	containing both transplanted cells and GFAP or NF reaction	11465
@VP	was calculated and expressed as a percentage of the field	11700
@VP	calculated and expressed as a percentage of the field	11704
@VP	were tested for locomotor function by two observers	11845
@VP	tested for locomotor function by two observers	11850
@VP	blinded to the treatment groups	11897
@VP	was performed weekly , beginning 1 week post-transplantation	11942
@VP	performed weekly , beginning 1 week post-transplantation	11946
@VP	beginning 1 week post-transplantation	11964
@VP	continued up to 6 weeks post-transplantation	12006
@VP	fixed stereotaxically	12194
@VP	reducing tracheal secretions	12268
@VP	placed on the surface of the sensorimotor cortex	12581
@VP	performing evoked potentials on all subjects	12888
@VP	evoked potentials on all subjects	12899
@VP	were removed for histological processing	12951
@VP	removed for histological processing	12956
@VP	was performed using two-tailed Student 's t test	13100
@VP	performed using two-tailed Student 's t test	13104
@VP	using two-tailed Student 's t test	13114
@VP	was applied to analyze the areas of GFAP and NF	13167
@VP	applied to analyze the areas of GFAP and NF	13171
@VP	to analyze the areas of GFAP and NF	13179
@VP	analyze the areas of GFAP and NF	13182
@VP	were rounded to three digits and less than 0.05 regarded as significant	13225
@VP	rounded to three digits and less than 0.05 regarded as significant	13230
@VP	regarded as significant	13273
@VP	to compare the values between groups	13307
@VP	compare the values between groups	13310
@VP	was calculated and indicated as ± value in the text and as SEM bars on graphs	13370
@VP	calculated and indicated as ± value in the text and as SEM bars on graphs	13374
@VP	transplanted to the contused spinal cord	13506
@VP	contused spinal cord	13526
@VP	formed groups under light microscope -LRB- a -RRB-	13596
@VP	separated by thin glial membrane -LRB- arrows -RRB-	13711
@VP	surrounded by some hypertrophic astrocytes -LRB- c -RRB-	13757
@VP	receiving OECs	13817
@VP	were more scattered within the spinal cord tissue	13854
@VP	receiving SCs	14167
@VP	was more enhanced	14198
@VP	penetrating into the injured area -LRB- a -RRB-	14275
@VP	receiving OECs	14326
@VP	were fewer	14365
@VP	was blurred -LRB- b -RRB-	14398
@VP	blurred -LRB- b -RRB-	14402
@VP	came up against astroglial tissue	14425
@VP	could transverse -LRB- b1 -RRB- , but not SCs -LRB- a1 -RRB-	14465
@VP	transverse -LRB- b1 -RRB- , but not SCs -LRB- a1 -RRB-	14471
@VP	was significantly higher in SCs injection than OECs injection	14618
@VP	0.05 compared with 3 weeks	14685
@VP	contused spinal cord	14811
@VP	could migrated into the normal tissue near to the injured area -LRB- b -RRB-	14942
@VP	migrated into the normal tissue near to the injured area -LRB- b -RRB-	14948
@VP	were significant larger and longer than that of SCs -LRB- c , d -RRB-	15065
@VP	induce the axons labeled by NF immunoreaction regenerated into the injured area	15303
@VP	labeled by NF immunoreaction	15320
@VP	regenerated into the injured area	15349
@VP	is further showed by the enlargers	15517
@VP	showed by the enlargers	15528
@VP	was smaller in SCs group than in OECs group	15673
@VP	was revealed by the statistical analysis	15764
@VP	revealed by the statistical analysis	15768
@VP	was decreased	16118
@VP	decreased	16122
@VP	was prolonged compared to the normal group	16148
@VP	prolonged compared to the normal group	16152
@VP	were significantly improved compared to DMEM group -LRB- c , d -RRB-	16206
@VP	improved compared to DMEM group -LRB- c , d -RRB-	16225
@VP	contused spinal cord at the T10 spinal level	16463
@VP	were activated at different extent by the transplanted cells	16524
@VP	activated at different extent by the transplanted cells	16529
@VP	received SCs	16602
@VP	proliferated and became larger in their cell body	16631
@VP	proliferated	16631
@VP	became larger in their cell body	16648
@VP	were separated into groups by the glial membrane -LRB- Fig. 1a -RRB-	16708
@VP	separated into groups by the glial membrane -LRB- Fig. 1a -RRB-	16713
@VP	were enveloped by a thin glial membrane	16861
@VP	enveloped by a thin glial membrane	16866
@VP	were surrounded by some hypertrophic astrocytes -LRB- Fig. 1c -RRB-	16922
@VP	surrounded by some hypertrophic astrocytes -LRB- Fig. 1c -RRB-	16927
@VP	observed under both light and electron microscopes	17057
@VP	to form a plenty of glial tissue -LRB- Fig. 1b , d -RRB-	17179
@VP	form a plenty of glial tissue -LRB- Fig. 1b , d -RRB-	17182
@VP	to assess the host astrocytes response following the injections of SCs and OECs	17295
@VP	assess the host astrocytes response following the injections of SCs and OECs	17298
@VP	widely used for detecting astrocytic responses to injury	17441
@VP	detecting astrocytic responses to injury	17457
@VP	enhanced GFAP expression	17524
@VP	penetrating into the injured area	17654
@VP	transverse against astroglial tissue while SCs can not -LRB- Fig. 2a1 , b1 -RRB-	17814
@VP	can not	17861
@VP	Quantifying the area of GFAP immunoreactivity	17884
@VP	were GFAP areas of 23.71 % and 28.24 % at 3 and 6 weeks , significantly	17971
@VP	were assessed at 3 and 6 weeks following transplantation	18236
@VP	assessed at 3 and 6 weeks following transplantation	18241
@VP	were densely distributed in the injured area at 3 weeks -LRB- Fig. 4a , b -RRB-	18311
@VP	densely distributed in the injured area at 3 weeks -LRB- Fig. 4a , b -RRB-	18316
@VP	became sparse at 6 weeks -LRB- Fig. 5a , b -RRB-	18384
@VP	was more concentrated than that of OECs in the contused spinal cord	18456
@VP	contused spinal cord	18503
@VP	could migrate longitudinally in the cord	18552
@VP	migrate longitudinally in the cord	18558
@VP	did not penetrate into the normal tissue , compared to OECs	18632
@VP	penetrate into the normal tissue , compared to OECs	18640
@VP	walked '' longer	18697
@VP	migrated into the normal tissue	18737
@VP	surviving	19071
@VP	packed loosely	19092
@VP	was significant -LRB- p < 0.05 -RRB- -LRB- Fig. 4c , d -RRB-	19350
@VP	typically exhibiting elongated morphologies	19506
@VP	elongated morphologies	19527
@VP	labeled by the NF immunoreaction to grow toward to the injured area	19574
@VP	to grow toward to the injured area	19607
@VP	grow toward to the injured area	19610
@VP	aligned longitudinally	19674
@VP	intercrossed with the axons -LRB- Fig. 5a -- d -RRB-	19773
@VP	was confirmed by quantifying the area of NF immunoreactivity	19944
@VP	confirmed by quantifying the area of NF immunoreactivity	19948
@VP	quantifying the area of NF immunoreactivity	19961
@VP	receiving animals	20061
@VP	receiving animals at 3 and 6 weeks , respectively	20115
@VP	was larger at 6 weeks than at 3 weeks within each group	20189
@VP	were revealed by the statistical analysis -LRB- Fig. 6 -RRB-	20292
@VP	revealed by the statistical analysis -LRB- Fig. 6 -RRB-	20297
@VP	injected rats	20686
@VP	scored 13.68 ± 1.20 , compared to 9.52 ± 0.95 for the DMEM rats	20754
@VP	was statistically detected	20879
@VP	is the astrocytic response to injury	21808
@VP	transplanting cells to replace or improve the inhibitory CNS glial environment	21900
@VP	to replace or improve the inhibitory CNS glial environment	21920
@VP	replace or improve the inhibitory CNS glial environment	21923
@VP	has practiced in many animal experiments	21979
@VP	practiced in many animal experiments	21983
@VP	interacting with astrocytes following implantation into the contused spinal cord	22094
@VP	contused spinal cord	22154
@VP	improved by either of SCs or OECs using BBB score and CSEP recording	22229
@VP	using BBB score and CSEP recording	22263
@VP	was more extensive in SCs cord than in OECs cord	22422
@VP	accompanied by a smaller distribution area than OECs	22517
@VP	did in the contused spinal cord	22570
@VP	contused spinal cord	22581
@VP	to regrow toward to the injured area	22777
@VP	regrow toward to the injured area	22780
@VP	contused spinal cord at 6 weeks after transplantation	22938
@VP	has potential for restoration of injured spinal cords	23100
@VP	to improve functional recovery -LRB- Garcia-Alias et al. 2004 -RRB-	23193
@VP	improve functional recovery -LRB- Garcia-Alias et al. 2004 -RRB-	23196
@VP	in vitro assays comparing the interactions between astrocytes	23290
@VP	intermingle in co-culture -LRB- Lakatos et al. 2000 ; Fairless et al. 2005 -RRB-	23477
@VP	undergo hypertrophy when in contact with SCs but not with OECs	23559
@VP	exhibit a poor capacity to migrate within astrocyte-rich areas	23627
@VP	to migrate within astrocyte-rich areas	23651
@VP	migrate within astrocyte-rich areas	23654
@VP	exist alongside astrocytes within the olfactory system -LRB- Doucette 1993 -RRB-	23811
@VP	is involved in the adhesion and migration of SCs and OECs	24387
@VP	involved in the adhesion and migration of SCs and OECs	24390
@VP	contacting with astrocytes -LRB- Wilby et al. 1999 ; Fairless et al. 2005 -RRB-	24450
@VP	plays an important role in axonal guidance -LRB- Ranscht 2000 -RRB-	24577
@VP	has important roles in neurulation -LRB- Takeichi et al. 1990 -RRB-	24667
@VP	bind to cadherin molecules on adjacent cells	24785
@VP	form adherent junctions between cells -LRB- Wanner and Wood 2002 -RRB-	24834
@VP	regulates adhesion between cells directly	24918
@VP	to promote neurite outgrowth	25011
@VP	promote neurite outgrowth	25014
@VP	using siRNA	25190
@VP	reduced heterotypic and homotypic adhesion	25350
@VP	gained adhesion properties more akin to OECs	25402
@VP	had little effect on their migration and adhesion when cultured with astrocytes	25496
@VP	cultured with astrocytes	25551
@VP	is differentially regulated in SCs and OECs -LRB- Fairless , et al. 2005 -RRB-	25614
@VP	regulated in SCs and OECs -LRB- Fairless , et al. 2005 -RRB-	25632
@VP	releasing insulin-like growth factor-1	25829
@VP	induced astrocytes to react more extensively	26297
@VP	to react more extensively	26316
@VP	react more extensively	26319
@VP	did after transplantation as revealed in the present study	26378
@VP	revealed in the present study	26407
@VP	regenerate toward to the injured regions	26480
@VP	contused spinal cords demonstrated by BBB score and CSEP recording	26553
@VP	demonstrated by BBB score and CSEP recording	26575
@VP	was not as ideal as that in the OECs group	26731
@VP	implying that SCs should be valuable for cell-mediated repair	26839
@VP	should be valuable for cell-mediated repair	26857
@VP	be valuable for cell-mediated repair	26864
@VP	can improve the structure and function of the injured spinal cord	26970
@VP	improve the structure and function of the injured spinal cord	26974
@VP	see Bunge 2008 ; Kocsis et al. 2009	27049
@VP	is more effective in promoting axonal sparing/regeneration	27164
@VP	promoting axonal sparing/regeneration	27185
@VP	contused thoracic	27308
@VP	supporting the ingrowth of axons	27457
@VP	generelated peptide-positive and supraspinal serotonergic axons	27530
@VP	increasing corticospinal axon numbers	27598
@VP	rostral to the injury -- graft site	27648
@VP	demonstrated modest improvements in open field locomotion	27713
@VP	exhibited less foot position errors -LRB- Barakat et al. 2005 -RRB-	27775
@VP	induced by SCs ' transplantation	27858
@VP	evoked responses following electrical stimulation -LRB- Pinzon et al. 2001 -RRB-	27926
@VP	diffuse into the contiguous host cord	28260
@VP	promote the axon to regenerate and sprout	28302
@VP	to regenerate and sprout	28319
@VP	regenerate and sprout	28322
@VP	released by them	28549
@VP	are involved in improving the structure and function of the contused spinal cord	28566
@VP	improving the structure and function of the contused spinal cord	28582
@VP	contused spinal cord	28626
@VP	induced more host astrocyte response and GFAP expression compared to OECs graft	28836
@VP	distributed smaller than OECs did in the contused spinal cord	28995
@VP	did in the contused spinal cord	29025
@VP	contused spinal cord	29036
@VP	was weaker in the SCs group	29209
@VP	could promote NF expression and restore the function of the contused spinal cord	29256
@VP	promote NF expression and restore the function of the contused spinal cord	29262
@VP	promote NF expression	29262
@VP	restore the function of the contused spinal cord	29288
@VP	contused spinal cord	29316
@VP	be a valuable candidate for cell-mediated repair of the injured spinal cord	29358
@VP	to provide maximal benefit for the recovery of the injured spinal cord	29444
@VP	provide maximal benefit for the recovery of the injured spinal cord	29447
@VP	promoting cell migration and axon regeneration	29584
@VP	should be performed in the future	29631
@VP	be performed in the future	29638
@VP	performed in the future	29641
